Mosspiration Biotech ApS: Financial statements 2022
CVR: 37414506
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Mosspiration Biotech ApS (CVR 37414506) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -20,331 and a net result of DKK -20,393 compared with DKK 11,803 the year before. Equity in the 2022 report amounted to DKK 18,280. The solvency ratio was 80.9%.
- Gross Profit
- DKK -20,331
- Profit/Loss
- DKK -20,393
- Equity
- DKK 18,280
- Total Assets
- DKK 22,590
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -20K | -20K | 18K | - |
| 2021 | - | 12K | 12K | 34K | - |
| 2020 | - | 38K | 37K | 2K | - |
| 2019 | - | 51K | 9K | -35K | - |
| 2018 | - | 160K | -121K | -44K | - |
Official annual report
Keep an eye on Mosspiration Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Mosspiration Biotech ApS has published its annual report for 2021. Gross profit came to DKK 12,003, and the net result was DKK 11,803.
About Mosspiration Biotech ApS
Mosspiration Biotech ApS was a Danish company of the type Anpartsselskab based in Glostrup, founded in 2016. The company has been dissolved on 14 August 2024. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named Mosspiration Biotech IVS. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -6,233 and a net result of DKK -6,233 compared with DKK -20,393 the year before. Equity in the 2023 report amounted to DKK 4,088.